Start-up Receives up to $15 M to Develop Nanoparticle Therapy for Sepsis Licensed from UC San Diego

San Diego-based Cellics Therapeutics, which was co-founded by UC San Diego nanoengineering Professor Liangfang Zhang, has received an award of up to $15M to develop a macrophage cellular nanosponge—nanoparticles cloaked in the cell membranes of macrophages—designed to treat sepsis.

Click to view original post